Viewing Study NCT00221312


Ignite Creation Date: 2025-12-26 @ 11:07 AM
Ignite Modification Date: 2025-12-29 @ 4:22 AM
Study NCT ID: NCT00221312
Status: COMPLETED
Last Update Posted: 2008-05-08
First Post: 2005-09-16
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Fosamax Bone Loss Study: Alendronate to Prevent Bone Loss
Sponsor: University of California, San Francisco
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2002-05
Start Date Type: None
Primary Completion Date: None
Primary Completion Date Type: None
Completion Date: 2007-07
Completion Date Type: ACTUAL
First Submit Date: 2005-09-16
First Submit QC Date: None
Study First Post Date: 2005-09-22
Study First Post Date Type: ESTIMATED
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2008-05-05
Last Update Post Date: 2008-05-08
Last Update Post Date Type: ESTIMATED